Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive HER2 Positive Breast Cancer from the 48th Annual San Antonio Breast Cancer Symposium
Event Date
Wednesday, February 25, 2026
1:30 PM - 2:30 PM ET
Presented in Collaboration with:
- Advanced Practitioner Society for Hematology and Oncology (APSHO)
- American Cancer Society
- American Psychosocial Oncology Society
- American Society of Clinical Oncology
- Association for Molecular Pathology
- Black Womens Health Imperative
- The Breast Cancer Research Foundation
- BreastCancerTrials.org
- Cancer Justice
- Cancer Nation
- Caregiver Action Network
- Living Beyond Breast Cancer
- National Comprehensive Cancer Network (NCCN) NCCN Guidelines for Patients
- The National Witness Project, Inc.
- NeedyMeds
- Prevent Cancer Foundation
- Redes en Acción The National Latino Cancer Research Network
- Research Advocacy Network
- Scott Hamilton CARES Foundation
- SHARE Cancer Support
- Sharsheret - The Jewish Breast and Ovarian Cancer Community
- Sisters Network Inc. - A National African American Breast Cancer Survivorship Organization
- Tigerlily Foundation
- TOUCH, The Black Breast Cancer Alliance
- Triage Cancer
- Young Survival Coalition
- Intercultural Cancer Council
This activity is supported by an educational grant from Daiichi Sankyo, Novartis Oncology, and a grant from Genentech. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.
Topics Covered
- Updates from the 48th Annual SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors
- What’s New in the Treatment of ER, PR & HER2 Positive Breast Cancer
- Updates from SABCS on Hormone & Targeted Therapy
- Chemotherapy Updates from SABCS
- Investigational New Drugs in Clinical Trials Reported at SABCS
- What’s New in Preventing & Managing Treatment Side Effects, including Discomfort, Neuropathy & Long-Term Effects of Treatment for Breast Cancer
- Key Questions to Ask Your Health Care Team
- Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Facilitators
Facilitator
Facilitator
Facilitator
Continuing Education Credits
Live Only
Social Workers: This program has been submitted to The University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).
Certified Health Education Specialists (CHES®): This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hour. Cancer Care, Inc is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
To request continuing education paperwork, please email your name, profession, and address to [email protected] after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.